NEW YORK (GenomeWeb) – Medicare administrative contractor Palmetto GBA finalized local coverage determinations for viral respiratory panels yesterday, determining that the use of small multiplex viral panels in susceptible populations may be reasonable and necessary, but the use of highly multiplexed nucleic acid amplification tests as front-line diagnostics cannot currently be justified.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.